Insider · CIK 0001065168
Kenneth J Widder
Files at EVOK (Evoke Pharma Inc), PSNL (Personalis, Inc.), QDEL (QuidelOrtho Corp). First filing Nov 25, 2025, latest Nov 25, 2025.
Kenneth J Widder files SEC Form 4 as director at QDEL (QuidelOrtho Corp), and also at EVOK (Evoke Pharma Inc), PSNL (Personalis, Inc.). Since Nov 25, 2025, Kenneth J Widder has reported 0 open-market buys worth $0 and 1 open-market sell worth $112k, the latest filed on Nov 25, 2025.
A track record needs three past buys with six months of prices behind them; Kenneth J Widder has 0, so none is measured yet.
The newest scored trade: sold $112k of QDEL on Nov 25, 2025, filed Nov 25, 2025, scored 10 (weak). In the last 12 months: 0 buys worth $0 and 1 sell worth $112k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
QDEL: QuidelOrtho Corp
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 10Weak | QDELsell QuidelOrtho Corp | $112k 4,026 shares | -10% | +43% from low-41% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Nov 25, 2025 | QDEL QUIDELORTHO CORPORATION | 4,026 0.01% of outstanding | $112k | Nov 25, 2025 | none |
Transactions
Every row this insider has filed, 29 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 25, 2026 | QDEL QuidelOrtho Corp | AGrant or award Restricted Stock Units (Equity Grant)derivative | +15,532 | $0.00 | $0 | 15,532 | Jun 29, 2026 |
| Jun 25, 2026 | QDEL QuidelOrtho Corp | AGrant or award Restricted Stock Units (Converted)derivative | +6,656 | $0.00 | $0 | 6,656 | Jun 29, 2026 |
| Jun 25, 2026 | QDEL QuidelOrtho Corp | AGrant or award Restricted Stock Units (Premium)derivative | +1,997 | $0.00 | $0 | 1,997 | Jun 29, 2026 |
| Jun 6, 2026 | QDEL QuidelOrtho Corp | AGrant or award Common Stock | +910 | $0.00 | $0 | 44,800 | Jun 9, 2026 |
| Jun 6, 2026 | QDEL QuidelOrtho Corp | AGrant or award Common Stock | +273 | $0.00 | $0 | 45,073 | Jun 9, 2026 |
| Jun 6, 2026 | QDEL QuidelOrtho Corp | MOption exercise Restricted Stock Units (Converted)derivative | -910 | $0.00 | $0 | 0 | Jun 9, 2026 |
| Jun 6, 2026 | QDEL QuidelOrtho Corp | MOption exercise Restricted Stock Units (Premium)derivative | -273 | $0.00 | $0 | 0 | Jun 9, 2026 |
| May 29, 2026 | QDEL QuidelOrtho Corp | AGrant or award Common Stock | +6,829 | $0.00 | $0 | 43,890 | Jun 2, 2026 |
| May 29, 2026 | QDEL QuidelOrtho Corp | MOption exercise Restricted Stock Units (Equity Grant)derivative | -6,829 | $0.00 | $0 | 0 | Jun 2, 2026 |
| May 12, 2026 | PSNL Personalis, Inc. | AGrant or award Common Stock | +6,250 | $0.00 | $0 | 6,250 | May 14, 2026 |
| May 12, 2026 | PSNL Personalis, Inc. | AGrant or award Stock Option (right to buy)derivative | +37,500 | $0.00 | $0 | 37,500 | May 14, 2026 |
| Dec 17, 2025 | EVOK Evoke Pharma Inc | DDisposition to issuer Stock Option (Right to Buy)derivative | -1,187 | - | - | 0 | Dec 17, 2025 |
| Dec 17, 2025 | EVOK Evoke Pharma Inc | DDisposition to issuer Stock Option (Right to Buy)derivative | -5,833 | - | - | 0 | Dec 17, 2025 |
| Dec 17, 2025 | EVOK Evoke Pharma Inc | DDisposition to issuer Stock Option (Right to Buy)derivative | -1,187 | - | - | 0 | Dec 17, 2025 |
| Nov 25, 2025 | QDEL QuidelOrtho Corp | MOption exercise Common Stock | +7,021 | $15.74 | $111k | 41,087 | Nov 25, 2025 |
| Nov 25, 2025 | QDEL QuidelOrtho Corp | SOpen-market sale Common Stock | -4,026 | $27.81 | $112k | 37,061 | Nov 25, 2025 |
| Nov 25, 2025 | QDEL QuidelOrtho Corp | MOption exercise Non-Qualified Stock Optionsderivative | -7,021 | $0.00 | $0 | 0 | Nov 25, 2025 |
| May 29, 2025 | QDEL QuidelOrtho Corp | AGrant or award Restricted Stock Units (Equity Grant)derivative | +6,829 | $0.00 | $0 | 6,829 | Jun 2, 2025 |
| May 29, 2025 | QDEL QuidelOrtho Corp | AGrant or award Restricted Stock Units (Converted)derivative | +2,926 | $0.00 | $0 | 2,926 | Jun 2, 2025 |
| May 29, 2025 | QDEL QuidelOrtho Corp | AGrant or award Restricted Stock Units (Premium)derivative | +878 | $0.00 | $0 | 878 | Jun 2, 2025 |
| May 22, 2025 | QDEL QuidelOrtho Corp | AGrant or award Common Stock | +4,929 | $0.00 | $0 | 34,066 | May 27, 2025 |
| May 22, 2025 | QDEL QuidelOrtho Corp | MOption exercise Restricted Stock Units (Equity Grant)derivative | -4,929 | $0.00 | $0 | 0 | May 27, 2025 |
| May 21, 2025 | EVOK Evoke Pharma Inc | AGrant or award Stock Option (Right to Buy)derivative | +1,187 | $0.00 | $0 | 8,207 | May 22, 2025 |
| May 18, 2025 | QDEL QuidelOrtho Corp | AGrant or award Common Stock | +512 | $0.00 | $0 | 28,984 | May 20, 2025 |
| May 16, 2025 | PSNL Personalis, Inc. | AGrant or award Stock Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | May 20, 2025 |
| May 18, 2025 | QDEL QuidelOrtho Corp | AGrant or award Common Stock | +153 | $0.00 | $0 | 29,137 | May 20, 2025 |
| May 18, 2025 | QDEL QuidelOrtho Corp | MOption exercise Restricted Stock Units (Converted)derivative | -512 | $0.00 | $0 | 0 | May 20, 2025 |
| May 18, 2025 | QDEL QuidelOrtho Corp | MOption exercise Restricted Stock Units (Premium )derivative | -153 | $0.00 | $0 | 0 | May 20, 2025 |
| Jan 28, 2025 | EVOK Evoke Pharma Inc | AGrant or award Stock Option (Right to Buy)derivative | +5,833 | $0.00 | $0 | 5,833 | Jan 29, 2025 |
Questions about Kenneth J Widder
Answered from the filings on this page, as of the latest one.
Is Kenneth J Widder buying or selling?
In the last 12 months Kenneth J Widder reported 0 open-market buys worth $0 and 1 open-market sell worth $112k on SEC Form 4; the latest was sold $112k of QDEL on Nov 25, 2025. Grants, option exercises and tax withholding are not counted.
How did Kenneth J Widder's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kenneth J Widder has 0.
Where does Kenneth J Widder file Form 4?
Kenneth J Widder has filed Form 4 at QDEL (QuidelOrtho Corp); EVOK (Evoke Pharma Inc); PSNL (Personalis, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.